Loading clinical trials...

A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT00557310

A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide

The purpose of this study is to use imaging technologies to demonstrate the effects of teriparatide on bone structure following 18 to 24 months of therapy in postmenopausal women with osteoporosis.

Lead sponsor: Eli Lilly and Company•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 4

Combined Anabolic Therapy

NCT06558188 · Osteoporosis, Postmenopausal, Osteoporosis

RECRUITING

Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

NCT05575167 · Osteoporosis, Postmenopausal

RECRUITINGNA

Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis

NCT05228262 · Osteoporosis, Postmenopausal

COMPLETEDNA

The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal Women

NCT06375668 · Osteoporosis, Postmenopausal, Bone Density, Low

WITHDRAWNPhase 4

Effect of Mechanical Loading With PTH on Cortical Bone

NCT03232476 · Osteoporosis, Postmenopausal

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 11, 2011Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment35

Start dateNov 2007

Last updatedNov 11, 2011

Condition

Osteoporosis, Postmenopausal

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Tucson, Arizona

Lakewood, Colorado

Omaha, Nebraska

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 11, 2011Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions